Normo- and hyperandrogenic women with polycystic ovary syndrome exhibit an adverse metabolic profile through life Pekka Pinola, Ph.D., Katri Puukka, Ph.D., Terhi T. Piltonen, Ph.D., Johanna Puurunen, Ph.D., Eszter Vanky, Ph.D., Inger Sundström- Poromaa, Ph.D., Elisabet Stener-Victorin, Ph.D., Angelica Lindén Hirschberg, Ph.D., Pernille Ravn, Ph.D., Marianne Skovsager Andersen, Ph.D., Dorte Glintborg, Ph.D., Jan Roar Mellembakken, Ph.D., Aimo Ruokonen, Ph.D., Juha S. Tapanainen, Ph.D., Laure C. Morin-Papunen, Ph.D. Fertility and Sterility Volume 107, Issue 3, Pages 788-795.e2 (March 2017) DOI: 10.1016/j.fertnstert.2016.12.017 Copyright © 2016 American Society for Reproductive Medicine Terms and Conditions
Figure 1 Body mass indices, waist circumferences, and parameters of glucose metabolism at different ages in the study populations. The bars represent means and the error bars standard deviations. Results are adjusted for body mass index. PCOS = polycystic ovary syndrome. Fertility and Sterility 2017 107, 788-795.e2DOI: (10.1016/j.fertnstert.2016.12.017) Copyright © 2016 American Society for Reproductive Medicine Terms and Conditions
Figure 2 Lipids at different ages in the study populations. The bars represent the means and the error bars the standard deviations. Results are adjusted for body mass index. PCOS = polycystic ovary syndrome. Fertility and Sterility 2017 107, 788-795.e2DOI: (10.1016/j.fertnstert.2016.12.017) Copyright © 2016 American Society for Reproductive Medicine Terms and Conditions